Navigation Links
Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents
Date:5/20/2008

ith coronary de novo lesions) allowed to verify, in a single trial, the safety and efficacy of the two novel drug-eluting stent formulations." He added that "Another important point is that most previous comparative trials between Sirolimus & Paclitaxel used stents with two different platforms and polymers." "In the PAINT -- which used the same metal platform and coating for both active stents -- the effects of Sirolimus and Paclitaxel could be compared in a more direct way, since the only difference between the stents was the drug itself," he explains.

Dr Atul Abhyankar, Medical Director- Sahajanand's Medical Technologies, shared the enthusiasm. "The results of the PAINT trial truly add to the interventional community learning about DESs, it clearly proves that the biodegradable polymer used by SMT is effective and safe vehicle for DES and seems to work efficiently irrespective of the type of drugs. Both drugs (Paclitaxel & Sirolimus) were effective in reducing restenosis on the same vehicle and platform. So you have a luxury of choice of drug based on your own assessment."

Mr. Dhirajlal Kotadia, the Founder and Chairman of SMT; emphasized the company's commitment towards further intensifying its clinical research initiatives and continue to deliver evidence-based treatments to all deserving patients around the world.

The Infinnium - CE mark approved, stent system utilizes paclitaxel, which has been shown to reduce tissue proliferation in the coronary vessels following stent implantation, and is based upon the easily deliverable, thinnest strut (0.0032") Matrix coronary stent platform.

Sahajanand Medical Technologies is (http://www.smtpl.com/) a global developer & manufacturers of minimally invasive coronary stents, with one of the broadest product portfolios in the industry. (Infinnium , Infinicore, Supralimus , Supracore, Coronnium and Matrix).

Company Profile: Sahajanand Medical
'/>"/>

SOURCE Sahajanand Medical Technologies Pvt. Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... -- Aspire Technology Partners (Aspire) announced today that it has ... designation recognizes Aspire for delivering outstanding customer service to customers ... "Achieving exceptional results for our customers is core ... and CEO of Aspire. "We are pleased Cisco has recognized ... and are proud to be part of the Cisco channel." ...
(Date:8/1/2014)... , Aug. 1, 2014 ... of the "Global Medical Biosensors Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Medical biosensors ... help of physicochemical detectors. These biosensors monitor health ... invasive and non-invasive methods. They are cost-effective and ...
(Date:8/1/2014)... CHICAGO , Ill. and PALO ALTO, ... ABBV) and Cystic Fibrosis Research, Inc. (CFRI) today announced a ... the cystic fibrosis (CF) community through the CFChef Shares ... September 15, 2014, as part of AbbVie,s CFChef program ... – to encourage patients to maintain a healthy diet ...
Breaking Medicine Technology:Aspire Technology Partners Recognized By Cisco For Excellence In Customer Satisfaction 2Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3
... NEW YORK, June 13, 2011 Reportlinker.com ... is available in its catalogue: ... in Key SADC Countries ... aim of this research service is to ...
... 2011 Science, public health, and regulatory highlights from ... this document is designed for credentialed journalists. Release dates and ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... or enforcement actions due to legal limitations. ...
Cached Medicine Technology:Reportlinker Adds Distributor Analysis of the Pharmaceutical Industry in Key SADC Countries 2Reportlinker Adds Distributor Analysis of the Pharmaceutical Industry in Key SADC Countries 3
(Date:8/1/2014)... Oxford Gene Technology (OGT) is a ... include CytoSure heamatological cancer +SNP Array, CytoSure ISCA ... array, CytoSure ISCA sample tracking spike-ins and CytoSure ... as targeted sequencing services, SureSeq Solid Tumour Panel ... analysis, cytosure services and aCGH for CNV analysis. ...
(Date:8/1/2014)... FRIDAY, Aug. 1, 2014 (HealthDay News) -- Roaming the ... preserved mummy became famous as the "Ice Man" no doubt ... of that may still not have shielded the Ice Man, ... A human,s genetic risk for atherosclerosis, or "hardening of the ... thousands of years ago, a new study finds. ...
(Date:8/1/2014)... LA The Health Resources and Services Administration ... Orleans School of Nursing an Advanced Nursing Education ... years. The funding will support training interprofessional teams ... for military veterans and diverse populations with behavioral ... DNP, CRNA, LSUHSC Nurse Anesthesia Program Director and ...
(Date:8/1/2014)... (GSA) the nation,s largest interdisciplinary organization devoted ... "Des" O,Neill, MA, MD, FRCPI, AGSF, FRCP(Glasg), FRCP, FRCP(Edin), ... the 2014 recipient of the Joseph T. Freeman Award. ... geriatrics and is awarded to a prominent physician in ... practice who is a member of the Society,s ...
(Date:8/1/2014)... 01, 2014 Lifeinsurancenomedicalexam.info has released ... insurance for clients who have high cholesterol levels. ... find and qualify for no medical exam life insurance. ... any background medical check-ups. , Since there are no ... level will qualify in just a few minutes. However, ...
Breaking Medicine News(10 mins):Health News:Oxford Gene Technology Market Size, Share, Analysis, Trends and Forecasts 2014 2Health News:Oxford Gene Technology Market Size, Share, Analysis, Trends and Forecasts 2014 3Health News:'Ice Man' Mummy May Have Been at Risk of Heart Disease 2Health News:LSUHSC Nursing awarded $1 million grant to improve care for veterans 2Health News:O'Neill to receive GSA's 2014 Joseph T. Freeman Award 2Health News:No Exam Life Insurance - Coverage for Clients Who Have High Cholesterol 2
... in French . A team of ... have discovered a type of "cellular bilingualism" a ... different methods of communication to exchange information. "Our work ... function of dopaminergic, serotonergic and cholinergic neurons in diseases ...
... By Alan Mozes HealthDay Reporter , THURSDAY, March ... therapy may have gotten a little closer to reality, with ... hearts that were dangerously swollen after heart attacks. The ... bone marrow, then injecting them into the patient,s damaged heart. ...
... , WEDNESDAY, March 16 (HealthDay News) -- ... children participating in their school,s band, a new study ... high school band and found they were heavily contaminated ... which are associated with minor to serious infections and ...
... for the first time that stem cells injected into ... improved function to injured heart areas, according to a ... the American Heart Association . , Researchers said that ... findings are promising for the more than five million ...
... increasing frequency, parents of children with autism spectrum disorder ... their children wander or unexpectedly run away. One mother ... wandered away from her home, despite efforts to lock ... this problem, Autism Speaks, the world,s largest autism science ...
... -- Many American children who qualify for public health ... parents are confused about enrollment and eligibility, new research ... low-income households in Oregon and found that about 23 ... were not enrolled in the Oregon Health Plan (OHP), ...
Cached Medicine News:Health News:'Bilingual' neurons may reveal the secrets of brain disease 2Health News:Stem Cell Therapy Shrinks Enlarged Hearts 2Health News:Stem Cell Therapy Shrinks Enlarged Hearts 3Health News:Heart damage improves, reverses after stem cell injections in a preliminary human trial 2Health News:Autism Speaks supports new diagnostic code for individuals with autism with history of wandering 2Health News:Parents Often Confused About Kids' Health Coverage 2
Designed to insert eye spheres using spring loaded plunger. Polished finish. Overall length: 125 mm, 4.9 inches....
Size: Medium. 22.50 mm by 24.00 mm. Clear lucite. Supplied sterile....
... x 100 mm. Storz offers the ... by Harvey A. Lincoff, M.D. ... sponge which is non-toxic and non-antigenic. ... to minimize scleral intrusion. These implants ...
... x 80 mm. Storz offers the ... by Harvey A. Lincoff, M.D. ... sponge which is non-toxic and non-antigenic. ... to minimize scleral intrusion. These implants ...
Medicine Products: